EverythingALS and NeuroSense take aim at Lou Gehrig’s disease

Mugglehead
By Joseph MortonAug 2, 2022, 10:12 pm279 pts
NeuroSense Therapeutics (NASDAQ:NRSN) and ALS-fighter, EverythingALS, are collaborating to identify treatments and a cure for ALS. EverythingALS was founded in 2020 to bring tech innovations and data science in support of efforts for people with ALS. The non-profit conducts tech-based research to help track ALS…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Minnesota issues first adult-use marijuana license to a cultivator 64

PinkPepper Genome Mapping Transforms CBD Hemp Cultivation and Research 64

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.